Sangamo Therapeutics, Inc. · NASDAQ:SGMO
Wasatch Advisors LP's stake in Sangamo Therapeutics, Inc. fell to 2.10% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 12, 2025
Wasatch Advisors LP's stake in Sangamo Therapeutics, Inc. fell to 2.10%, 6,188,358 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).
- Stake
- 2.10%
- Shares
- 6,188,358
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wasatch Advisors LP | 2.10% | 6,188,358 |
Source
Related
- Sangamo Therapeutics, Inc.
- Wasatch Advisors LP
- Sangamo Therapeutics, Inc. shareholders
- Schedule 13G/A · Wasatch Advisors LP · May 12, 2025
- Schedule 13G/A · Wasatch Advisors LP · Jan 7, 2025
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Davis Gregory D · May 27, 2026
- Form 4 · Jain Nikunj · May 27, 2026
- Form 4 · Dubois-Stringfellow Nathalie · May 27, 2026
- Form 4 · Willoughby Scott B. · May 27, 2026